Idioma:

Heat Shock Protein 90: Inhibitors in Clinical Trials

Biamonte, Marco A ; Van de Water, Ryan ; Arndt, Joseph W ; Scannevin, Robert H ; Perret, Daniel ; Lee, Wen-Cherng

Journal of medicinal chemistry, 2010-01, Vol.53 (1), p.3-17 [Periódico revisado por pares]

Texto completo disponível

Citações Citado por

Título:
Heat Shock Protein 90: Inhibitors in Clinical Trials
Autor: Biamonte, Marco A ; Van de Water, Ryan ; Arndt, Joseph W ; Scannevin, Robert H ; Perret, Daniel ; Lee, Wen-Cherng
Assuntos: Animals ; Antineoplastic agents ; Benzamides - chemical synthesis ; Benzamides - chemistry ; Benzamides - pharmacology ; Benzoquinones - chemical synthesis ; Benzoquinones - chemistry ; Benzoquinones - pharmacology ; Biological and medical sciences ; Clinical Trials as Topic ; Drug Design ; Drug Screening Assays, Antitumor ; General aspects ; HSP90 Heat-Shock Proteins - antagonists & inhibitors ; HSP90 Heat-Shock Proteins - metabolism ; Humans ; Lactams, Macrocyclic - chemical synthesis ; Lactams, Macrocyclic - chemistry ; Lactams, Macrocyclic - pharmacology ; Medical sciences ; Molecular Structure ; Pharmacology. Drug treatments ; Purines - chemical synthesis ; Purines - chemistry ; Purines - pharmacology ; Resorcinols - chemical synthesis ; Resorcinols - chemistry ; Resorcinols - pharmacology ; Structure-Activity Relationship
É parte de: Journal of medicinal chemistry, 2010-01, Vol.53 (1), p.3-17
Notas: ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Editor: Columbus, OH: American Chemical Society
Idioma: Inglês

Links

Voltar para lista de resultados